Abdullah A. Emran

Missenden Road
Camperdown, NSW 2050, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

H3K4me3 remodeling induced acquired resistance through O-GlcNAc transferase.

H3K4me3 remodeling induced acquired resistance through O-GlcNAc transferase.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: February 14, 2023

Systems biology and in silico-based analysis of PCOS revealed the risk of metabolic disorders.

Systems biology and in silico-based analysis of PCOS revealed the risk of metabolic disorders.

Journal: Heliyon

Published: February 04, 2022

Nicotinamide Inhibits T Cell Exhaustion and Increases Differentiation of CD8 Effector T Cells.

Nicotinamide Inhibits T Cell Exhaustion and Increases Differentiation of CD8 Effector T Cells.

Journal: Cancers

Published: December 16, 2021

Dual Targeting with EZH2 Inhibitor and STING Agonist to Treat Melanoma.

Dual Targeting with EZH2 Inhibitor and STING Agonist to Treat Melanoma.

Journal: The Journal of investigative dermatology

Published: September 24, 2021

Repurposing Melanoma Chemotherapy to Activate Inflammasomes in the Treatment of BRAF/MAPK Inhibitor Resistant Melanoma.

Repurposing Melanoma Chemotherapy to Activate Inflammasomes in the Treatment of BRAF/MAPK Inhibitor Resistant Melanoma.

Journal: The Journal of investigative dermatology

Published: June 22, 2021

Lysine Demethylases: Promising Drug Targets in Melanoma and Other Cancers.

Lysine Demethylases: Promising Drug Targets in Melanoma and Other Cancers.

Journal: Frontiers in genetics

Published: March 15, 2021

DPP9: Comprehensive In Silico Analyses of Loss of Function Gene Variants and Associated Gene Expression Signatures in Human Hepatocellular Carcinoma.

DPP9: Comprehensive In Silico Analyses of Loss of Function Gene Variants and Associated Gene Expression Signatures in Human Hepatocellular Carcinoma.

Journal: Cancers

Published: March 12, 2021

Sex bias of females in survival from cancer and infections. Is X the answer?

Sex bias of females in survival from cancer and infections. Is X the answer?

Journal: British journal of cancer

Published: November 12, 2020

A Combination of Epigenetic BET and CDK9 Inhibitors for Treatment of Human Melanoma.

A Combination of Epigenetic BET and CDK9 Inhibitors for Treatment of Human Melanoma.

Journal: The Journal of investigative dermatology

Published: October 01, 2020

Study of the Female Sex Survival Advantage in Melanoma-A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts.

Study of the Female Sex Survival Advantage in Melanoma-A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts.

Journal: Cancers

Published: June 26, 2020

Do innate killing mechanisms activated by inflammasomes have a role in treating melanoma?

Do innate killing mechanisms activated by inflammasomes have a role in treating melanoma?

Journal: Pigment cell & melanoma research

Published: November 27, 2019

Pretreatment Innate Cell Populations and CD4 T Cells in Blood Are Associated With Response to Immune Checkpoint Blockade in Melanoma Patients.

Pretreatment Innate Cell Populations and CD4 T Cells in Blood Are Associated With Response to Immune Checkpoint Blockade in Melanoma Patients.

Journal: Frontiers in immunology

Published: September 30, 2019

Showing 1-12 of 23

Last Updated: 09/26/2026